A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
Tanaka Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, et al. Mod Rheumatol. 2007; 17(3):191-7. Epub 2007 Jun 20.